1. Home
  2. HKD vs ZVRA Comparison

HKD vs ZVRA Comparison

Compare HKD & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AMTD Digital Inc. (every five of which represent two)

HKD

AMTD Digital Inc. (every five of which represent two)

N/A

Current Price

$1.68

Market Cap

512.3M

Sector

Finance

ML Signal

N/A

Logo Zevra Therapeutics Inc.

ZVRA

Zevra Therapeutics Inc.

N/A

Current Price

$12.34

Market Cap

562.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HKD
ZVRA
Founded
2003
2006
Country
France
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
512.3M
562.2M
IPO Year
2021
2015

Fundamental Metrics

Financial Performance
Metric
HKD
ZVRA
Price
$1.68
$12.34
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$23.00
AVG Volume (30 Days)
98.0K
880.3K
Earning Date
02-27-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
159.21
EPS
N/A
0.74
Revenue
N/A
$106,470,000.00
Revenue This Year
N/A
$37.27
Revenue Next Year
N/A
$53.42
P/E Ratio
$14.10
$16.62
Revenue Growth
N/A
350.91
52 Week Low
$1.26
$7.16
52 Week High
$5.47
$15.04

Technical Indicators

Market Signals
Indicator
HKD
ZVRA
Relative Strength Index (RSI) 51.64 59.73
Support Level $1.60 $12.18
Resistance Level $1.70 $14.27
Average True Range (ATR) 0.06 0.36
MACD -0.00 0.10
Stochastic Oscillator 23.53 95.31

Price Performance

Historical Comparison
HKD
ZVRA

About HKD AMTD Digital Inc. (every five of which represent two)

AMTD Digital Inc along with its subsidiaries, is mainly involved in the provision of digital solutions services. Its reportable segments are digital solutions services segment; hotel operations, hospitality and VIP services segment; media and entertainment services segment; and Strategic investments. The company generates maximum revenue from Digital solutions services segment, which provides its institutional and corporate clients with exclusive, paid access to enhance their investor communication, investor relations and corporate communication to potentially maximize their valuation, as well as providing digital solution services. Geographically, the company generates revenue from China, Hong Kong, Europe, Americas and Southeast Asia.

About ZVRA Zevra Therapeutics Inc.

Zevra Therapeutics Inc is a commercial-stage company with a late-stage pipeline committed to bringing life-changing therapeutics to people living with rare diseases. The Company is focused on expanding patient access, progressing its pipeline toward key milestones, and delivering meaningful outcomes for patients with unmet needs. The commercialization of its product, marketed in the United States for Niemann-Pick disease type C (NPC), a rare, progressive neurodegenerative disease, provides a corporate foundation and demonstrates its ability to advance therapies from development to market.

Share on Social Networks: